Expert Interview
A discussion on the standard of care and unmet needs in the acne treatment landscape, and the generic vs branded drugs available for acne treatment.
Ticker(s): IBBInstitution: Private Practice
- Manages several patients a week with HS, and those with very severe HS requiring hospitalization about 2 times per month.
Familiar with JAK inhibitors in the pipeline for HS and have seen an article about the Phase II trial for this medication.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
